Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human prothrombin complex for hemophilia B bleeding
CTR20170646Phase 3Completed
- Sponsor
- Guangdong Weilun Biopharmaceutical
- Start
- Jun 2017
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of balfaxar in hemophilia B (HB), sponsored by Guangdong Weilun Biopharmaceutical. Started Jun 2017; status: completed.
02
Drugs
balfaxar
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20170646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170646.